Title |
COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma / Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K. Eigentler, Janina Remy, Katharina Schober, Markus V. Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzmer ; Herausgeber: Adam C. Berger |
|---|---|
Involved |
Carola Berking (Verfasser)
Elisabeth Livingstone (Verfasser) Dirk Debus (Verfasser) Carmen Loquai (Verfasser)
Michael Weichenthal (Verfasser)
Ulrike Leiter-Stöppke (Verfasser) Felix Kiecker (Verfasser) Peter Mohr (Verfasser) Thomas Eigentler (Verfasser) Janina Remy (Verfasser) Katharina Schober (Verfasser) Markus V. Heppt (Verfasser) Imke von Wasielewski (Verfasser) Dirk Schadendorf (Verfasser) Ralf Gutzmer (Verfasser) Adam C. Berger (Herausgeber) |
Published |
Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
melanoma
BRAF mutation MAPK pathway dabrafenib
trametinib
brain metastases tumor dynamics |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024032008160809833870 (URN) |
Further information |
In: Cancers 15.18 (2023). DOI:10.3390/cancers15184436 |
Record ID |
1323969306 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: